Guidelines for hormone treatment of women in the menopausal transition and beyond.
Naftolin
F
F
Schneider
H P G
HP
Sturdee
D W
DW
D000368:Aged; D015914:Estrogen Replacement Therapy / Q000009:adverse effects / Q000379:methods / Q000592:standards; D004967:Estrogens / Q000008:administration & dosage / Q000009:adverse effects; D005060:Europe; D005260:Female; D006801:Humans; D008593:Menopause; D008875:Middle Aged; D011372:Progestins / Q000008:administration & dosage / Q000009:adverse effects; D016032:Randomized Controlled Trials as Topic; D014481:United States; D014486:United States Food and Drug Administration
D004967:Estrogens; D011372:Progestins